Summary
Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA), discusses the neuroscience of addiction, how substances hijack the brain's reward circuitry, and the latest research on drug abuse prevention and treatment. As one of the world's leading authorities on addiction, Volkow brings deep expertise on the dopaminergic system, the neurobiology of compulsive behavior, and evidence-based approaches to understanding and treating substance use disorders.
Key Points
- The neuroscience of addiction and how substances hijack reward circuitry
- How the dopaminergic system drives compulsive behavior
- Evidence-based approaches to drug abuse prevention and treatment
- Latest research from NIDA on substance use disorders
- Understanding addiction as a brain disease rather than moral failing
Key Moments
Psilocybin for Addiction: NIDA Director on the Promising Evidence
Dr. Nora Volkow, Director of NIDA, explains why she funded psychedelic research with humans and discusses the promising but preliminary evidence for psilocybin in treating depression, PTSD, nicotine addiction, and alcohol use disorder. She notes the effect sizes for smoking cessation appear larger than FDA-approved medications, but cautions that sample sizes are small and replication is essential.
"The data is strongest for the use of psilocybin for depression."
Low-Intensity Ultrasound: A Potential Cure for Addiction?
Volkow introduces low-intensity focused ultrasound as a breakthrough neuromodulation technology for addiction treatment. Unlike TMS, ultrasound penetrates deep into the brain to directly target the nucleus accumbens. Pilot data shows a single 10-minute session producing effects lasting 2-4 weeks, with results as dramatic as deep brain stimulation but completely non-invasive.
"The beauty of the low intensity is you do not produce damage to the tissue, but you can modify it for a long time."
Addiction as Brain Disorder: How Drugs Create Artificial Needs
Volkow explains the common neurocircuitry underlying all addictions: drugs create long-term potentiation in reward circuits while weakening signaling for natural rewards, essentially creating an artificial need for the drug as strong as the need for food. She draws a striking parallel between addiction and chronic pain, where the memory of pleasure or pain persists long after the original stimulus is gone.
"you generate it in such a way that you've created an artificial need for the drug, just like you have a need for food. Now you have an artificial need for the drug."
